Arvinas Inc (NASDAQ:ARVN)

42.55
Delayed Data
As of Jul 01
 +0.46 / +1.09%
Today’s Change
34.90
Today|||52-Week Range
108.47
-48.20%
Year-to-Date

Today’s Trading

Previous close42.09
Today’s open41.57
Day’s range40.97 - 42.61
Volume6,305
Average volume (3 months)475,193
Market cap$2.4B
Data as of 3:59pm ET, 07/01/2022

Growth & Valuation

Earnings growth (last year)-26.56%
Earnings growth (this year)-16.00%
Earnings growth (next 5 years)-13.13%
Revenue growth (last year)+114.20%
P/E ratioNM
Price/Sales87.94
Price/Book3.11

Competitors

----
FATEFate Therapeutics In...+0.39+1.57%
TWSTTwist Bioscience Cor...+2.14+6.12%
BCRXBioCryst Pharmaceuti...+0.26+2.46%
Data as of 4:00pm ET, 07/01/2022

Financials

Next reporting dateAugust 9, 2022
EPS forecast (this quarter)-$1.09
Annual revenue (last year)$46.7M
Annual profit (last year)-$191.0M
Net profit margin-408.99%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
New Haven, Connecticut

Forecasts